• 7
  • 1
  • 1

Some Investors Should Buy Novavax Stock on the Dip

InvestorPlace2022-01-04

Novavax(NASDAQ:NVAX) still remains poised to sell its vaccine for the coronavirus to many countries around the world, likely enabling it to generate very strong revenue in 2022 and possibly into 2023....

网页链接

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

举报

评论1

  • XLMM
    ·2022-01-04
    Have been buying the dips!
    回复
    举报
 
 
 
 

热议股票

 
 
 
 
 

7x24